Quote: Someone posted that "common sense" suggests that EUA

New Post Public Reply Private Reply Replies (0) Message Board
Goosebumps nothingspecial #85286
792
Quote: Someone posted that "common sense" suggests that EUA would make enrolling patients in CD16 & CD17 impossible. Who would risk getting placebo.

I am pretty sure a conformational trial does not have to use placebo. They have other ways to compare an average mortality from an average of other trials.

When you look at today’s headline in the PR. Does it make sense to think that EUA is on the cusp? Saying the non-dilutive financing is for manufacturing is a big deal. There was many ways to present this financing. But only for manufacturing??? That is a hammer title of that PR. It is telling me we didn’t need this financing for helping with our trial. All though some might be used for that. It really is just saying we need a whole bunch more than our 1.2 million doses we currently have. This is excellent news and shows without saying what is happening with the FDA in my opinion.

All though the first few sales will really fund our need for manufacturing. $25 million will only fund 350,000 or less doses. Or is it just the down payment for a larger order? If we sell the 1.2 million doses it is worth around $2 billion. That will be our cash needed for manufacturing cash to flow to buy any needed doses as we complete sales agreements across the world.

Maybe I am reading to much into the financing headline. I don’t think I am though... I feel it is a perfect match to where we are with talks with the FDA and all the changes that have happened to the trials and nothing solid in a protocol. Cytodyn has been throwing everything at the wall and hoping it would stick and the last finding of 82% at 14 days improved mortality must of been a home run and changed everything the way the FDA viewed the trial. Because the other two trials were designed then tossed for a 4 dose trial. The half life must of been recognized as the issue and now the FDA is a believer. Could it be? Is this what is happening behind closed doors? Will tomorrow be an announcement of EUA? I want to believe that. It sounds entirely possible. It’s a puzzle and when you look at all the pieces. It says something is happening now not later. Could be a good day tomorrow... we will see...

Read More: https://investorshangout.com/post/newpost/605...z6rAES2SQg

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Data Turing Unveils Innovative Platform to Transform Brand Reputation

Updated Category News Views 156

Introducing Data Turing's Groundbreaking Platform Data Turing, a cutting-edge technology company, has officially launched a trailblazing platform that is set to change the way brands manage their reputation. This innovative service automates the development of brand narratives through verifiable data, a significant step forward in a world where misinformation is...

Continue Reading
Elif Aral Appointed President of Pfizer for MERA Region

Updated Category News Views 124

Pfizer Welcomes New Leadership for the MERA Region Pfizer has recently appointed Elif Aral as the Regional President for the Middle East, Russia, and Africa (MERA). This important decision is aimed at strengthening operations across a variety of therapeutic areas, such as oncology, vaccines, internal medicine, and immunology. Enhancing Access to Healthcare In her new...

Continue Reading
Innovative Framework Enhances Fragrance Safety in Waterways

Updated Category News Views 116

Innovative Framework for Fragrance Safety This new approach enhances the safety of aquatic ecosystems. Aurelia Lapczynski, the Principal Scientist at the Research Institute for Fragrance Materials (RIFM), is at the forefront of an essential evolution in assessing fragrance safety in aquatic environments. A newly released manuscript brings significant advancements to how...

Continue Reading
Cryptocurrency Markets Shift Amid Rate Cut Speculation and Trends

Updated Category News Views 204

Bitcoin Experiences Decline as Market Dynamics Shift In the evolving landscape of cryptocurrency, leading assets have shown a divergence from stock performance recently. On a day characterized by mixed reactions to weak job data, Bitcoin's value fluctuated. Recent Price Movements At one point, Bitcoin dropped to an intraday low of $109,347.23 before making a modest...

Continue Reading
Guardian Capital Group Ltd. Invites Shareholders to Upcoming Meeting

Updated Category News Views 139

Important Shareholder Meeting Announcement The Board of Directors of Guardian Capital Group Limited (TSX: GCG) has made a crucial recommendation for its shareholders regarding an upcoming vote that could shape the future of the company. The directors, some of whom abstained from the voting process due to conflicts of interest, recommend that investors vote FOR the...

Continue Reading